Drugs / Lodosyn
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | LODOSYN | — | 1977-04-25 | fda.gov ↗ |
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04764383 | Jan → Oct 2022 | multiple sclerosis | University of Miami | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lodosyn | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04764383 ↗ |
| Route | Oral | “taken PO” NCT04764383 ↗ |